Multivisceral Transplant is a Viable Treatment Option for Patients with Nonresectable Intraabdominal Fibromatosis

ConclusionsMVT is a viable option for patients who have nonresectable intraabdominal fibromatosis with promising surviving rates, although recurrence still occurs. Surgical margin, Ki67 proliferative index, β‐catenin, and p53 expression are not predicative for recurrence of fibromatosis.This article is protected by copyright. All rights reserved.

Source: Clinical Transplantation - December 1, 2017 Category: Transplant Surgery Authors: Zhikai Chi, Richard S Mangus, Chandrashekhar A. Kubal, Shaoxiong Chen, Jingmei Lin Tags: Original Article Source Type: research